Dean Rebouche explains what “enforcement discretion” is and how the FDA can use it to ensure continued access to mifepristone. Read More

As the legal battles churn over access to abortion pills, Dean Rachel Rebouche is clear on the bottom line: “Mifepristone is still on the market, mifepristone is still safe. Nothing immediately has changed.” Read More

While nothing has changed yet in the battle over mifepristone, Dean Rebouche notes that if the Fifth Circuit decision is upheld, it could put an end to delivery through the mail. Read More

Idaho’s governor denies claims that its new abortion law restricts the right to interstate travel, but Dean Rebouche says that right “doesn’t mean anything” for people who now fear leaving the state because they’ll be punished when they return. Read More

Federal courts in Texas and Washington state could soon issue opposing orders concerning access to abortion pills, which Dean Rachel Rebouche says could send abortion regulation back to the Supreme Court. Read More

Elevated Access provides private flights for people who need to travel across state lines for abortion care. Dean Rachel Rebouche says it’s an example of how abortion-rights advocates have been nimble amid legal uncertainty. Read More

Did plaintiffs’ lawyer in the Texas abortion pill case strike a death blow to their own claims? Dean Rebouche and co-authors David S. Cohen and Greer Donley say that if law and logic hold, the case should be dead. Read More

Anti-abortion strategists are testing the limits of how we understand what’s “legal.” Dean Rachel Rebouche says they’re “throwing everything at the wall to see what sticks.” Read More

Dean Rebouche offers her analysis of Walgreens’ decision not to dispense abortion pills, the pending Texas case, and the legal road ahead. Read More

Pharmacies face mounting pressure from abortion advocates and opponents over the sale of mifepristone, one of two drugs used in self-managed abortions. Dean Rachel Rebouche says the issue will be a focal point for legislators and activists in the coming years. Read More